- Clarke, Jennifer;
- Seo, Youngho;
- Chang, Susan;
- Barajas, RF;
- Pampaloni, MH;
- Clarke, JL;
- Savic, D;
- Hawkins, RA;
- Behr, SC;
- Chang, SM;
- Berger, M;
- Dillon, WP
We present our initial experience in using single modality fluoromisonidazole (FMISO) PET/MR imaging to noninvasively evaluate the biological effects induced by bevacizumab therapy in a patient treated for recurrent high grade glioma. In this index patient